Unibest
← Back to patent-cliff list

CAS 1392213-15-8

(1-Aminocyclobutyl)methanol hydrogen chloride

Codes: (IXb)805433-1-a,(IXb)805433-1-c

Application context (from source-drug indications)

Idiopathic pulmonary fibrosisNerandomilastInterstitial lung diseaseNerandomilastPulmonary fibrosisNerandomilast肌炎NerandomilastSystemic sclerosisNerandomilast肌病Nerandomilast

Source drugs (routes using this intermediate)

DrugTierExpiry
NerandomilastTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

NerandomilastOptimised routesteps: 8total yield: /
NerandomilastOptimised routesteps: 3total yield: /

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works(1-aminocyclobutyl)methanol hydrochloride
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.